Nucleic acids encoding novel orphan cytokine receptors
AssigneeRegeneron Pharmaceuticals, Inc.
InventorPiotr J. Masiakowski
Life of this patent
Estimating the term…
Abstract
The present invention provides for nucleic acid sequences that encode novel mammalian receptor polypeptides, designated OCR1. The invention also provides assay systems that may be used to detect and/or measure ligands that bind the MAMMALIAN OCR1 gene product. The present invention also provides for diagnostic and therapeutic methods based on the interaction between MAMMALIAN OCR1 and agents that initiate signal transduction through binding to MAMMALIAN OCR1. In a specific embodiment, the MAMMALIAN OCR1 may HUMAN OCR1 or MOUSE OCR1.
Claims7
An isolated nucleic acid molecule, having a sequence selected from the group consisting of:
- (a) the nucleotide sequence comprising the coding region of the HUMAN OCR1 as set forth in SEQ. ID. NO. 3;
- (b) the nucleotide sequence comprising the coding region of the HUMAN OCR1 as set forth in SEQ. ID. NO. 5;
- (c) a nucleotide sequence that hybridizes under stringent conditions to the nucleotide sequence of (a) or (b) and which encodes HUMAN OCR1, wherein said stringent conditions are 30% formamide in 5×SSPE (0.18 M NaCl, 0.01 M NaPO4, pH 7.7, 0.001 M EDTA) buffer at a temperature of 42° C. and remaining bound when subject to washing at 42° C. with 0.2×SSPE;
- or
- (d) a nucleotide sequence which, as a result of the degeneracy of the genetic code differs from the nucleic acid of (a), (b) or (c) and which encodes HUMAN OCR1.
An isolated nucleic acid molecule encoding MOUSE OCR1 as set forth in SEQ. ID. NO.:
- 1.
Dependencies are inferred from the claim text.